A clinical study to determine the efficacy and safety of an investigational medication (MK0869) in the treatment of depression.
The duration of treatment is 8 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
450
HAMD-17 total score at week 8. Tolerability.
Time frame: at week 8
CGI-I score at week 8, at least 50% reduction in the HAMD-17 total score, and Sheehan Disability Score at Week 8
Time frame: at week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.